Amreen Husain, MD is an accomplished physician and drug developer who brings more than a decade of experience across large pharma and small biotech. Her extensive experience in oncology drug development spans all phases and multiple therapeutic areas and modalities including immuno-oncology, ADCs, large and small molecules; as well as a multiple global regulatory filings.
Amreen joins us from Gilead Sciences where she was VP of Oncology Clinical Development and led the International Development team in building Gilead’s global clinical teams across the EMEA, APAC AND LATAM regions; in addition, she was a key member of the corporate development late-stage oncology group. Prior to Gilead she was SVP at EQRX and led development for multiple portfolio products in oncology and inflammatory disease and at Bolt Biotherapeutics where she led clinical development for novel immune-stimulating antibody drug conjugates (ISACs). Amreen started her career in industry at Genentech where she was clinical lead on multiple global regulatory filings for Avastin in gynecologic cancers and then built the development program for Tecentriq in breast and gynecologic cancers. She was the cross-indication team lead for Tecentriq and was instrumental in leading and developing the strategy for the first to market sub-cutaneous CPI. Her experience includes being a Therapeutic area head in safety sciences for ophthalmology, immunology and infectious diseases.
Amreen is passionate about drug development and bringing innovative, impactful therapies to patients. She is a board-certified gynecologic oncologist who completed her residency and fellowship trainings at Cornell University Hospital and Memorial Sloan-Kettering Cancer Center respectively. Following her training she held a faculty position at Stanford University School of Medicine where she was a key member of the cancer center’s clinical trials scientific committee as well as a PI on multiple industry and cooperative group trials and a member on cooperative group committees. She completed her medical education at New York Medical College, NY and her undergraduate education with a degree in Chemistry and Philosophy at Bryn Mawr College, PA.
